Immunocore Holdings (IMCR)

Immunocore Holdings on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances).

Download CSV

7.8M

Short interest

settlement 2026-10-15

15.7

Days to cover

-5.0 days vs prior

43.0%

Short share of volume

2026-11-02

219

Fails to deliver

settlement 2026-10-14

Thu 5 Nov

Next earnings

estimated date

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in IMCR is 7,801,461 shares, up 31,219 shares over the last month. Over the last 48 readings it ranged from 6,711,947 shares (15 January 2025) to 11,984,360 shares (27 February 2026). At the reported average volume of 498K shares a day that is 15.7 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/imcr" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	7,801,461	-1.3%	498,403	15.65
2026-09-30	7,903,280	+1.7%	381,726	20.70
2026-09-15	7,770,242	-0.3%	377,893	20.56
2026-08-31	7,793,032	-1.3%	374,592	20.80
2026-08-14	7,895,815	-3.9%	420,023	18.80
2026-07-31	8,217,977	-8.1%	472,941	17.38
2026-07-15	8,940,861	-0.6%	707,799	12.63
2026-06-30	8,992,351	-0.5%	718,644	12.51
2026-06-15	9,039,457	+3.3%	423,008	21.37
2026-05-29	8,749,260	-2.5%	443,958	19.71
2026-05-15	8,970,345	+0.0%	253,399	35.40
2026-04-30	8,969,565	-8.3%	430,960	20.81
2026-04-15	9,781,949	-3.6%	433,319	22.57
2026-03-31	10,144,803	+0.1%	389,375	26.05
2026-03-13	10,137,184	-15.4%	356,307	28.45
2026-02-27	11,984,360	+5.5%	381,304	31.43
2026-02-13	11,360,037	+3.9%	386,539	29.39
2026-01-30	10,931,087	+9.1%	623,530	17.53
2026-01-15	10,015,378	+5.2%	393,360	25.46
2025-12-31	9,520,098	+5.2%	260,233	36.58
2025-12-15	9,052,969	+5.7%	290,162	31.20
2025-11-28	8,564,719	-2.3%	388,459	22.05
2025-11-14	8,767,994	+1.3%	258,609	33.90
2025-10-31	8,655,047	-0.1%	272,692	31.74
2025-10-15	8,659,919	+3.6%	361,465	23.96
2025-09-30	8,359,661	-3.8%	315,017	26.54
2025-09-15	8,693,710	-0.4%	292,914	29.68
2025-08-29	8,729,838	-0.9%	258,195	33.81
2025-08-15	8,811,183	+5.7%	347,551	25.35
2025-07-31	8,339,072	-1.2%	260,626	32.00
2025-07-15	8,440,494	-0.6%	275,213	30.67
2025-06-30	8,487,193	+1.5%	380,626	22.30
2025-06-13	8,363,728	+4.4%	574,109	14.57
2025-05-30	8,010,529	+0.8%	535,620	14.96
2025-05-15	7,951,194	-0.0%	314,744	25.26
2025-04-30	7,953,871	+3.5%	266,192	29.88
2025-04-15	7,681,100	-4.9%	433,062	17.74
2025-03-31	8,076,037	+6.4%	451,001	17.91
2025-03-14	7,587,433	+2.1%	267,276	28.39
2025-02-28	7,431,084	+0.2%	262,957	28.26
2025-02-14	7,418,062	+1.1%	142,700	51.98
2025-01-31	7,338,968	+9.3%	202,174	36.30
2025-01-15	6,711,947	-0.2%	311,343	21.56
2024-12-31	6,725,686	-4.7%	391,728	17.17
2024-12-13	7,056,471	-1.8%	232,608	30.34
2024-11-29	7,187,346	-5.5%	238,957	30.08
2024-11-15	7,603,632	-4.6%	256,739	29.62
2024-10-31	7,969,448	-4.3%	225,042	35.41

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of IMCR volume is 43.0%, up 2.8 points over the last five sessions. Over the last 30 readings it ranged from 9.0% (7 October 2026) to 64.1% (30 October 2026). The latest reading is 8.2 points above the 30-session average of 34.8%, on 104K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-11-02	45K	104K	43.0%	0
2026-10-30	49K	76K	64.1%	0
2026-10-29	81K	878K	9.2%	0
2026-10-28	43K	76K	56.9%	0
2026-10-27	63K	141K	44.4%	0
2026-10-26	30K	74K	40.2%	0
2026-10-23	30K	87K	34.3%	0
2026-10-22	49K	118K	41.2%	0
2026-10-21	205K	686K	29.9%	68,200
2026-10-20	107K	349K	30.6%	0
2026-10-19	48K	105K	46.0%	0
2026-10-16	154K	334K	46.2%	0
2026-10-15	55K	138K	40.1%	0
2026-10-14	69K	214K	32.0%	1,000
2026-10-13	235K	521K	45.1%	0
2026-10-12	34K	88K	38.5%	0
2026-10-09	58K	202K	28.7%	0
2026-10-08	43K	209K	20.6%	0
2026-10-07	18K	198K	9.0%	0
2026-10-06	41K	376K	10.9%	0
2026-10-05	29K	139K	21.0%	0
2026-10-02	87K	316K	27.6%	0
2026-10-01	154K	376K	40.9%	0
2026-09-30	72K	279K	25.9%	0
2026-09-29	30K	141K	21.1%	0
2026-09-28	25K	106K	23.3%	0
2026-09-25	47K	116K	40.7%	0
2026-09-24	94K	242K	39.0%	0
2026-09-23	71K	138K	51.7%	6,300
2026-09-22	55K	133K	41.3%	0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 14 October 2026, the fails-to-deliver balance in IMCR is 219 shares, down 77 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (11 May 2026) to 170,319 shares (6 April 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-10-14	219	$27.82	$6K
2026-10-08	296	$29.41	$9K
2026-09-03	105	$37.37	$4K
2026-08-31	20	$36.62	$732
2026-08-28	3,999	$36.75	$147K
2026-08-21	856	$36.28	$31K
2026-08-20	19,780	$36.86	$729K
2026-08-17	47	$34.21	$2K
2026-08-10	36,955	$34.00	$1.3M
2026-08-03	298	$33.81	$10K
2026-07-23	103	$35.54	$4K
2026-07-07	15	$31.94	$479
2026-06-26	10	$30.54	$305
2026-06-23	10	$29.35	$294
2026-06-15	99	$28.96	$3K
2026-06-08	15	$28.29	$424
2026-06-04	1,796	$28.65	$51K
2026-06-03	42,269	$29.56	$1.2M
2026-06-02	41,325	$29.13	$1.2M
2026-05-29	4,079	$28.97	$118K
2026-05-28	293	$28.52	$8K
2026-05-26	328	$28.83	$9K
2026-05-11	2	$29.58	$59
2026-05-07	2,033	$30.73	$62K
2026-05-04	93,336	$28.16	$2.6M
2026-04-29	77,812	$28.79	$2.2M
2026-04-22	65,063	$29.52	$1.9M
2026-04-20	6,508	$31.45	$205K
2026-04-07	130,441	$31.94	$4.2M
2026-04-06	170,319	$30.83	$5.3M

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for IMCR in the last 90 days. The most recent filings are listed below. Latest filing: St Leger Tina Amber (CHIEF HR OFFICER) on 2026-02-18.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-02-18	St Leger Tina Amber	CHIEF HR OFFICER	Sell	1K	$32.35	$32K	1K
2026-02-18	Jallal Bahija	CHIEF EXECUTIVE OFFICER	Sell	11K	$32.35	$371K	12K
2026-02-18	GOLL JOHN	SVP, FINANCE & CAO	Sell	698	$32.35	$23K	653
2026-02-18	Berman David M	HEAD OF R&D	Sell	6K	$32.35	$193K	6K
2026-02-17	St Leger Tina Amber	CHIEF HR OFFICER	Exercise or conversion	2K	$0.00	$0	2K
2026-02-17	Jallal Bahija	CHIEF EXECUTIVE OFFICER	Exercise or conversion	24K	$0.00	$0	24K
2026-02-17	GOLL JOHN	SVP, FINANCE & CAO	Exercise or conversion	1K	$0.00	$0	1K
2026-02-17	Berman David M	HEAD OF R&D	Exercise or conversion	12K	$0.00	$0	12K
2025-12-05	Berman David M	HEAD OF R&D	Sell	572	$40.14	$23K	0
2025-12-05	Berman David M	HEAD OF R&D	Exercise or conversion	572	$17.46	$10K	572
2025-12-04	Berman David M	HEAD OF R&D	Sell	31K	$40.26	$1.3M	0
2025-12-04	Berman David M	HEAD OF R&D	Exercise or conversion	31K	$17.46	$547K	31K
2025-11-28	Berman David M	HEAD OF R&D	Sell	6K	$40.09	$221K	0
2025-11-28	Berman David M	HEAD OF R&D	Exercise or conversion	6K	$17.46	$96K	6K
2025-11-26	Berman David M	HEAD OF R&D	Sell	69K	$40.12	$2.8M	0
2025-11-26	Berman David M	HEAD OF R&D	Exercise or conversion	69K	$17.46	$1.2M	69K
2025-11-25	Berman David M	HEAD OF R&D	Sell	18K	$40.03	$721K	0
2025-11-25	Berman David M	HEAD OF R&D	Exercise or conversion	18K	$17.46	$315K	18K
2025-11-24	Berman David M	HEAD OF R&D	Sell	100	$40.00	$4K	0
2025-11-24	Berman David M	HEAD OF R&D	Exercise or conversion	100	$17.46	$2K	100
2025-09-30	Berman David M	HEAD OF R&D	Sell	62K	$35.23	$2.2M	0
2025-09-30	Berman David M	HEAD OF R&D	Exercise or conversion	62K	$17.46	$1.1M	62K
2025-09-15	Berman David M	HEAD OF R&D	Sell	200	$35.01	$7K	0
2025-09-15	Berman David M	HEAD OF R&D	Exercise or conversion	200	$17.46	$3K	200
2025-09-12	Berman David M	HEAD OF R&D	Sell	1K	$36.31	$47K	0
2025-09-12	Berman David M	HEAD OF R&D	Sell	21K	$35.63	$756K	1K
2025-09-12	Berman David M	HEAD OF R&D	Exercise or conversion	23K	$17.46	$393K	23K
2025-09-11	Berman David M	HEAD OF R&D	Sell	19K	$36.28	$692K	0
2025-09-11	Berman David M	HEAD OF R&D	Exercise or conversion	19K	$17.46	$333K	19K
2025-09-10	Berman David M	HEAD OF R&D	Sell	1K	$36.77	$44K	0
2025-09-10	Berman David M	HEAD OF R&D	Sell	30K	$36.12	$1.1M	1K
2025-09-10	Berman David M	HEAD OF R&D	Exercise or conversion	31K	$17.46	$547K	31K
2025-03-17	667, L.P.	Director	Buy	646K	$29.74	$19.2M	2.1M
2025-03-17	667, L.P.	Director	Buy	9K	$29.56	$254K	179K
2025-03-17	667, L.P.	Director	Buy	92K	$29.56	$2.7M	2.1M
2025-03-17	667, L.P.	Director	Buy	60K	$29.74	$1.8M	170K
2024-04-01	St Leger Tina Amber	CHIEF HR OFFICER	Sell	4K	$64.06	$280K	0
2024-04-01	St Leger Tina Amber	CHIEF HR OFFICER	Exercise or conversion	4K	$29.87	$131K	4K
2024-02-28	Berman David M	HEAD OF R&D	Sell	7K	$68.84	$514K	12K
2024-02-28	Berman David M	HEAD OF R&D	Sell	11K	$69.73	$763K	1K
2024-02-28	Berman David M	HEAD OF R&D	Sell	1K	$70.45	$85K	0
2024-02-28	Berman David M	HEAD OF R&D	Exercise or conversion	37K	$17.46	$637K	37K
2024-02-28	Berman David M	HEAD OF R&D	Sell	17K	$67.61	$1.1M	20K
2024-02-27	Berman David M	HEAD OF R&D	Sell	4K	$69.45	$309K	50K
2024-02-27	Berman David M	HEAD OF R&D	Sell	3K	$71.97	$244K	0
2024-02-27	Berman David M	HEAD OF R&D	Sell	26K	$71.32	$1.9M	3K
2024-02-27	Berman David M	HEAD OF R&D	Sell	21K	$70.42	$1.5M	29K
2024-02-27	Berman David M	HEAD OF R&D	Exercise or conversion	55K	$17.46	$959K	55K
2024-02-26	Berman David M	HEAD OF R&D	Exercise or conversion	29K	$17.46	$499K	29K
2024-02-26	Berman David M	HEAD OF R&D	Sell	27K	$70.60	$1.9M	2K
2024-02-26	Berman David M	HEAD OF R&D	Sell	2K	$71.31	$145K	0
2024-01-03	St Leger Tina Amber	Chief HR Officer	Exercise or conversion	4K	$29.87	$131K	4K
2024-01-03	St Leger Tina Amber	Chief HR Officer	Sell	4K	$69.85	$284K	307
2024-01-03	St Leger Tina Amber	Chief HR Officer	Sell	307	$70.46	$22K	0

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

5 Form 144 notices on file for IMCR worth $6.4M at the prices reported; 0 in the last 90 days worth $0. Latest: David Berman filed on 2026-03-11 to sell 11,832 shares ($385K) from 2026-03-11.

Filed	Seller	Shares	Market value	Of outstanding	Sale from	Broker
2026-03-11	David Bermanaffiliate	12K	$385K	0.023%	2026-03-11	J.P. Morgan Securities LLC
2026-02-18	Tina St Legeraffiliate	1K	$32K	0.002%	2026-02-18	J.P. Morgan Securities LLC
2026-02-18	Bahija Jallalaffiliate	11K	$371K	0.023%	2026-02-18	J.P. Morgan Securities LLC
2026-02-18	David Bermanaffiliate	6K	$193K	0.012%	2026-02-18	J.P. Morgan Securities LLC
2025-11-24	David M. BermanOfficer	137K	$5.4M	0.271%	2025-11-24	J.P. Morgan Securities LLC

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

8 holders report 5% or more of IMCR in their latest filing, all on Schedule 13G (passive). The largest reported stake is Wellington Management Group LLP at 11.6% of the class (5,959,773 shares), filed 2026-08-13 for an event on 2026-06-30.

Filed	Form	Holder	Shares	Of class	Event
2026-10-07	13G/Ano. 2	Abigail P. Johnsonindividual	1.7M	3.6%	2026-09-30
2026-10-07	13G/Ano. 2	FMR LLCparent holding company	1.7M	3.6%	2026-09-30
2026-08-14	13G/Ano. 1	Vestal Point Capital, LPinvestment adviser, partnership	1.8M	3.5%	2026-06-30
2026-08-14	13G/Ano. 1	Ryan Wilderparent holding company, individual	1.8M	3.5%	2026-06-30
2026-08-13	13G/Ano. 6	Wellington Management Group LLPparent holding company	6.0M	11.6%	2026-06-30
2026-08-13	13G/Ano. 6	Wellington Group Holdings LLPparent holding company	6.0M	11.6%	2026-06-30
2026-08-13	13G/Ano. 6	Wellington Investment Advisors Holdings LLPparent holding company	6.0M	11.6%	2026-06-30
2026-08-13	13G/Ano. 6	Wellington Management Company LLPinvestment adviser	6.0M	11.4%	2026-06-30
2026-05-15	13G/Ano. 5	T. Rowe Price Investment Management, Inc.investment adviser	1.9M	3.7%	2026-03-31
2025-11-14	13G	Bellevue Group AGparent holding company, corporation	2.8M	5.6%	2025-08-20
2025-11-14	13G	Bellevue Asset Management AGcorporation	2.8M	5.6%	2025-08-20
2025-10-24	13G	TANG CAPITAL MANAGEMENT, LLCother entity	2.6M	5.2%	2025-10-17
2025-10-24	13G	KEVIN TANGindividual	2.6M	5.2%	2025-10-17
2025-10-24	13G	TANG CAPITAL PARTNERS, LPpartnership	1.6M	3.2%	2025-10-17
2025-10-24	13G	TANG CAPITAL PARTNERS INTERNATIONAL, LPpartnership	1.0M	2.0%	2025-10-17
2025-10-24	13G	TANG CAPITAL PARTNERS III, INCcorporation	0	0.0%	2025-10-17
2025-10-24	13G	TANG CAPITAL PARTNERS IV, INCcorporation	0	0.0%	2025-10-17
2025-10-03	13G/Ano. 1	ELI LILLY & Cocorporation	0	0.0%	2025-09-30
2025-10-03	13G/Ano. 1	ELI LILLY S.A.corporation	0	0.0%	2025-09-30

13F holders

Tracked managers holding IMCR at their latest 13F. JSON

7 of the 30 tracked managers held IMCR at their latest 13F, $169.8M in total at quarter-end prices. Two Sigma Investments is the largest at $52.4M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 2 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Two Sigma Investments	2026-06-30	1.6M	$52.4M	0.04%	+628K
Millennium Management	2026-06-30	1.6M	$50.7M	0.02%	+360K
Point72 Asset Management	2026-06-30	990K	$31.4M	0.03%	-112K
Citadel Advisors	2026-06-30	567K	$18.0M	0.00%	+336K
D. E. Shaw & Co.	2026-06-30	405K	$12.9M	0.01%	+70K
Renaissance Technologies	2026-06-30	102K	$3.3M	0.00%	-62K
Bridgewater Associates	2026-06-30	37K	$1.2M	0.00%	+18K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In Q2 FY 2026 (quarter ended 2026-06-30) Immunocore Holdings reported revenue of $115.9M, up 18.3% from the same quarter a year earlier, and net loss of $808K (-0.02 diluted EPS). In FY 2025 it generated -$10.7M of operating cash flow.

Cash: $484.9M
Equity: $419.8M
Total assets: $1.12B
Shares outstanding: 51,498,617

Quarterly, last 8 quarters

Quarter	Period end	Revenue	Net income	Margin	Diluted EPS
Q2 FY 2026	2026-06-30	$115.9M	-$808K	-0.7%	-0.02
Q1 FY 2026	2026-03-31	$106.7M	$13.0M	12.2%	0.25
Q4 FY 2025derived	2025-12-31	$104.5M	-$30.1M	-28.8%	n/a
Q3 FY 2025	2025-09-30	$103.7M	-$177K	-0.2%	0.00
Q2 FY 2025	2025-06-30	$98.0M	-$10.3M	-10.5%	-0.20
Q1 FY 2025	2025-03-31	$93.9M	$5.0M	5.4%	0.10
Q4 FY 2024derived	2024-12-31	$84.1M	-$23.8M	-28.3%	n/a
Q3 FY 2024	2024-09-30	$80.2M	$8.7M	10.9%	0.17

Fiscal years, with buybacks and dividends

Fiscal year	Ends	Revenue	Net income	Operating cash flow	Capex	Buybacks	Dividends
FY 2025	2025-12-31	$400.0M	-$35.5M	-$10.7M	$4.3M	n/a	n/a
FY 2024	2024-12-31	$310.2M	-$51.1M	$26.1M	$5.2M	n/a	n/a
FY 2023	2023-12-31	$249.4M	-$55.3M	$2.9M	$5.4M	n/a	n/a
FY 2022	2022-12-31	$174.4M	-$52.5M	-$49.2M	$2.2M	n/a	n/a
FY 2021	2021-12-31	$4.1M	-$180.0M	-$143.1M	$1.4M	n/a	n/a

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.

What this page is

Immunocore Holdings in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Immunocore Holdings (IMCR), SEC CIK 1671927, listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
Planned sales: SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-03-11.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-07.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Financials: SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-02-18.JSON and CSV
Company record: EDGAR filing index for CIK 1671927Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as biological products, (no diagnostic substances)

Other company pages

Datasets

Frequently Asked Questions

How much of IMCR is sold short?

7,801,461 shares were held short at the 2026-10-15 settlement, 15.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is IMCR's daily short volume?

On 2026-11-02, 44,921 of the 104,466 IMCR shares reported to FINRA were sold short, 43.0% of the day's reported volume. Short volume is a flow for one day, not a position.

Does IMCR have fails to deliver?

The SEC's latest file shows 219 IMCR shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.

Are IMCR insiders buying or selling?

No open-market insider trades were reported for IMCR in the last 90 days. The most recent filings are listed below. Latest filing: St Leger Tina Amber (CHIEF HR OFFICER) on 2026-02-18.

Have IMCR insiders filed to sell?

5 Form 144 notices on file for IMCR worth $6.4M at the prices reported; 0 in the last 90 days worth $0. Latest: David Berman filed on 2026-03-11 to sell 11,832 shares ($385K) from 2026-03-11.

Who owns 5% or more of IMCR?

What did IMCR report last quarter?

Which tracked 13F managers own IMCR?

7 of the 30 tracked 13F managers held IMCR shares at their latest filing, $169.8M in all. The largest: Two Sigma Investments (1.6M shares, $52.4M), Izzy Englander's Millennium Management (1.6M shares, $50.7M), Steve Cohen's Point72 Asset Management (990K shares, $31.4M), Ken Griffin's Citadel Advisors (567K shares, $18.0M), D. E. Shaw & Co. (405K shares, $12.9M), Renaissance Technologies (102K shares, $3.3M). The table above lists all 7.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.